Upgrade to SI Premium - Free Trial

Kiniksa Pharmaceuticals Ltd. (KNSA)

51.58 +2.31 (4.69%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/28/26)

Latest Headlines

Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Quart Barry D June 2, 2026 4:52 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Popovits Kimberly J June 2, 2026 4:51 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Jun 01 Filed by: Patel Sanj K June 2, 2026 4:50 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: McCain Tracey L June 2, 2026 4:48 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Malley Thomas June 2, 2026 4:47 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Levy Richard S June 2, 2026 4:45 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: Cole G Bradley June 2, 2026 4:43 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 29 Filed by: 667, L.P. June 2, 2026 4:31 PM - SEC Filing Form 8-K Kiniksa Pharmaceuticals For: May 29 May 29, 2026 4:35 PM - SEC Filing Kiniksa Pharmaceuticals to Present at Upcoming Investor Conferences May 29, 2026 4:01 PM - Globe NewsWire Form SCHEDULE 13D/A Kiniksa Pharmaceuticals Filed by: BAKER BROS. ADVISORS LP May 26, 2026 5:05 PM - SEC Filing Form 8-K Kiniksa Pharmaceuticals For: May 21 May 26, 2026 4:55 PM - SEC Filing Form SCHEDULE 13G/A Kiniksa Pharmaceuticals Filed by: FMR LLC May 6, 2026 11:24 AM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 01 Filed by: Paolini John F. May 5, 2026 4:54 PM - SEC Filing Form 144 Kiniksa Pharmaceuticals Filed by: Paolini John F. May 1, 2026 4:46 PM - SEC Filing Form 8-K Kiniksa Pharmaceuticals For: Apr 30 May 1, 2026 4:34 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: May 01 Filed by: Patel Sanj K May 1, 2026 4:33 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 28 Filed by: Patel Sanj K April 30, 2026 6:33 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 28 Filed by: Quart Barry D April 29, 2026 4:46 PM - SEC Filing Kiniksa (KNSA) PT Raised to $57 at Wells Fargo April 29, 2026 8:24 AM - StreetInsider Form 144 Kiniksa Pharmaceuticals Filed by: Patel Sanj K April 28, 2026 4:49 PM - SEC Filing Form 10-Q Kiniksa Pharmaceuticals For: Mar 31 April 28, 2026 4:17 PM - SEC Filing Kiniksa (KNSA) PT Raised to $60 at Goldman Sachs April 28, 2026 1:31 PM - StreetInsider Kiniksa (KNSA) PT Raised to $71 at Jefferies April 28, 2026 12:56 PM - StreetInsider Kiniksa (KNSA) PT Raised to $65 at TD Cowen April 28, 2026 12:09 PM - StreetInsider Kiniksa Pharmaceuticals, Ltd. (KNSA) Tops Q1 EPS by 6c ; Offers Guidance April 28, 2026 8:12 AM - StreetInsider Form 8-K Kiniksa Pharmaceuticals For: Apr 28 April 28, 2026 7:32 AM - SEC Filing Kiniksa Pharmaceuticals Reports First Quarter 2026 Financial Results and Recent Portfolio Execution April 28, 2026 7:30 AM - StreetInsider Kiniksa Pharmaceuticals to Report First Quarter 2026 Financial Results on April 28, 2026 April 23, 2026 4:01 PM - StreetInsider Form ARS Kiniksa Pharmaceuticals For: Dec 31 April 16, 2026 4:35 PM - SEC Filing Form DEFA14A Kiniksa Pharmaceuticals April 16, 2026 4:33 PM - SEC Filing Form DEF 14A Kiniksa Pharmaceuticals For: May 19 April 16, 2026 4:32 PM - SEC Filing Kiniksa (KNSA) PT Raised to $58 at Wedbush April 16, 2026 8:02 AM - StreetInsider Form 4 Kiniksa Pharmaceuticals For: Apr 09 Filed by: Megna Michael R April 13, 2026 4:36 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 09 Filed by: Moat Ross April 13, 2026 4:35 PM - SEC Filing Form 144 Kiniksa Pharmaceuticals Filed by: Moat Ross April 9, 2026 4:04 PM - SEC Filing Form 144 Kiniksa Pharmaceuticals Filed by: Megna Michael R April 9, 2026 4:03 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 07 Filed by: Tessari Eben April 8, 2026 4:45 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 07 Filed by: Ragosa Mark April 8, 2026 4:44 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 06 Filed by: Patel Sanj K April 8, 2026 4:43 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 07 Filed by: Paolini John F. April 8, 2026 4:42 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 06 Filed by: Moat Ross April 8, 2026 4:40 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 07 Filed by: Megna Michael R April 8, 2026 4:39 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 06 Filed by: Quart Barry D April 8, 2026 4:35 PM - SEC Filing Kiniksa Pharmaceuticals Launches Targeted Direct-To-Consumer TV Campaign for ARCALYST® (rilonacept) in Recurrent Pericarditis April 8, 2026 8:00 AM - Globe NewsWire Form 144 Kiniksa Pharmaceuticals Filed by: Quart Barry D April 6, 2026 4:56 PM - SEC Filing Form 144 Kiniksa Pharmaceuticals Filed by: Patel Sanj K April 6, 2026 4:54 PM - SEC Filing Form 144 Kiniksa Pharmaceuticals Filed by: Moat Ross April 6, 2026 4:05 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Jan 15 Filed by: Tessari Eben April 3, 2026 4:41 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 01 Filed by: Ragosa Mark April 3, 2026 4:40 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 01 Filed by: Patel Sanj K April 3, 2026 4:39 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Apr 01 Filed by: Paolini John F. April 3, 2026 4:37 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Jan 15 Filed by: Moat Ross April 3, 2026 4:36 PM - SEC Filing Form 4 Kiniksa Pharmaceuticals For: Jan 15 Filed by: Megna Michael R April 3, 2026 4:35 PM - SEC Filing Form SCHEDULE 13G/A Kiniksa Pharmaceuticals Filed by: VANGUARD GROUP INC March 27, 2026 10:18 AM - SEC Filing Full Article List